Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 11/2015

01-11-2015 | Letter to the Editors

Authors’ reply concerning the letter by Ensminger et al.

Authors: Michael Weis, Gerhard Steinbeck, Bruno Reichart, Tassilo Hübner, Thomas Nickel, Steffen Massberg, Rene Schramm, Christian Hagl, Axel Kiwi

Published in: Clinical Research in Cardiology | Issue 11/2015

Login to get access

Excerpt

We strongly disagree with the comments of Ensminger et al. (Clin Res Cardiol, doi:10.​1007/​s00392-015-0903-7), out of the following reasons: …
Literature
1.
Hubner T, Nickel T, Steinbeck G, Massberg S, Schramm R, Reichart B, Hagl C, Kiwi A, Weis M (2015) A single german center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list. Clin Res Cardiol (Epub ahead of print)
2.
Silvetti S, Greco T, Licia Di Prima A, Mucchetti M, Maria de Lurdes C, Pasin L, Scandroglio M, Landoni G, Zangrillo A (2014) Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials. Clin Res Cardiol 103:505–513CrossRefPubMed
3.
Thackray S, Easthaugh J, Freemantle N, Cleland JG (2002) The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta-regression analysis. Eur J Heart Fail 4:515–529CrossRefPubMed
4.
Erlemeier HH, Kupper W, Bleifeld W (1992) Intermittent infusion of dobutamine in the therapy of severe congestive heart failure–long-term effects and lack of tolerance. Cardiovasc Drugs Ther 6:391–398CrossRefPubMed
5.
Hatzizacharias A, Makris T, Krespi P, Triposkiadis F, Voyatzi P, Dalianis N, Kyriakidis M (1999) Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. Am Heart J 138:241–246CrossRefPubMed
6.
Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas JN (2012) Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Int J Cardiol 159:225–229CrossRefPubMed
7.
Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV (2007) Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153:98–104CrossRefPubMed
8.
Levine BS (2000) Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure. J Cardiovasc Nurs 14:76–93CrossRefPubMed
9.
Felker GM, O’Connor CM (2001) Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 142:393–401CrossRefPubMed
10.
Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT (2006) Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Heart 92:1768–1772PubMedCentralCrossRefPubMed
11.
O’Connor CM, Gattis WA, Uretsky BF, Adams KF, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM (1999) Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the flolan international randomized survival trial (first). Am Heart J 138:78–86CrossRefPubMed
12.
13.
Jessup M, Banner N, Brozena S, Campana C, Costard-Jackle A, Dengler T, Hunt S, Metra M, Rahmel A, Renlund D, Ross H, Warner Stevenson L (2006) Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant 25:1003–1023CrossRefPubMed
14.
Teerlink JR, Metra M, Zaca V, Sabbah HN, Cotter G, Gheorghiade M, Cas LD (2009) Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. Heart Fail Rev 14:243–253PubMedCentralCrossRefPubMed
15.
Metadata
Title
Authors’ reply concerning the letter by Ensminger et al.
Authors
Michael Weis
Gerhard Steinbeck
Bruno Reichart
Tassilo Hübner
Thomas Nickel
Steffen Massberg
Rene Schramm
Christian Hagl
Axel Kiwi
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 11/2015
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0908-2

Other articles of this Issue 11/2015

Clinical Research in Cardiology 11/2015 Go to the issue

Review

Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014

Original Paper

Catheter ablation of pediatric AV nodal reentrant tachycardia: results in small children

Original Paper

Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up

Original Paper

A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list

Original Paper

Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR

Original Paper

Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits